Recordati Industria Chimica e Farmaceutica S.p.A.

LSE:0KBS Stock Report

Market Cap: €10.7b

Recordati Industria Chimica e Farmaceutica Future Growth

Future criteria checks 3/6

Recordati Industria Chimica e Farmaceutica is forecast to grow earnings and revenue by 11.5% and 7% per annum respectively. EPS is expected to grow by 11.9% per annum. Return on equity is forecast to be 29.3% in 3 years.

Key information

11.5%

Earnings growth rate

11.9%

EPS growth rate

Pharmaceuticals earnings growth19.6%
Revenue growth rate7.0%
Future return on equity29.3%
Analyst coverage

Good

Last updated19 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0KBS - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,7065846397387
12/31/20252,5675395686738
12/31/20242,3244696026769
9/30/20242,269423476530N/A
6/30/20242,224387114481N/A
3/31/20242,139389154528N/A
12/31/20232,082389102485N/A
9/30/20232,032375134510N/A
6/30/20232,005389438507N/A
3/31/20231,985340360456N/A
12/31/20221,853312367462N/A
9/30/20221,801331391485N/A
6/30/20221,702330422504N/A
3/31/20221,615393445491N/A
12/31/20211,580386404492N/A
9/30/20211,511377373475N/A
6/30/20211,460365303413N/A
3/31/20211,404334259425N/A
12/31/20201,449355272404N/A
9/30/20201,475389-112362N/A
6/30/20201,499391-84388N/A
3/31/20201,528388-101336N/A
12/31/20191,482369-125319N/A
9/30/20191,439328210318N/A
6/30/20191,399322202301N/A
3/31/20191,369318249346N/A
12/31/20181,352312273358N/A
9/30/20181,338307270362N/A
6/30/20181,333306N/A307N/A
3/31/20181,313297N/A277N/A
12/31/20171,288289N/A273N/A
9/30/20171,255275N/A244N/A
6/30/20171,217262N/A286N/A
3/31/20171,194250N/A273N/A
12/31/20161,154237N/A255N/A
9/30/20161,126229N/A266N/A
6/30/20161,096218N/A261N/A
3/31/20161,074212N/A258N/A
12/31/20151,048199N/A247N/A
9/30/20151,030190N/A231N/A
6/30/20151,019181N/A217N/A
3/31/20151,003170N/A198N/A
12/31/2014987161N/A179N/A
9/30/2014982156N/A192N/A
6/30/2014972146N/A167N/A
3/31/2014957139N/A167N/A
12/31/2013942134N/A171N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0KBS's forecast earnings growth (11.5% per year) is above the savings rate (2.1%).

Earnings vs Market: 0KBS's earnings (11.5% per year) are forecast to grow slower than the UK market (14.6% per year).

High Growth Earnings: 0KBS's earnings are forecast to grow, but not significantly.

Revenue vs Market: 0KBS's revenue (7% per year) is forecast to grow faster than the UK market (3.6% per year).

High Growth Revenue: 0KBS's revenue (7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 0KBS's Return on Equity is forecast to be high in 3 years time (29.3%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y